CTOs on the Move

Elcelyx Therapeutics

www.elcelyx.com

 
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.elcelyx.com
  • 11995 El Camino Real Suite 305
    San Diego, CA USA 92130-2567
  • Phone: 858.876.1814

Executives

Name Title Contact Details

Funding

Elcelyx Therapeutics raised $40M on 10/01/2015

Similar Companies

Sonus USA

Sonus USA is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Convacare

Convacare is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emergency Ambulance Service

Emergency Ambulance Service is a Brea, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Patterson Veterinary Supply

Patterson Veterinary Supply, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Patterson Veterinary Supply, Inc is based in Devens, MA. You can find more information on Patterson Veterinary Supply, Inc at www.webstervet.com

Novocardia

Novocardia is on a mission to transform how cardiovascular disease care is delivered in the United States, and aims to help patients with heart and vascular disease live longer, healthier, and more satisfying lives. We are committed to putting cardiologists, and their patients, at the center of care by investing in our partner practices, deploying purpose-built data and analytics tools to improve patient outcomes, and enabling our partners to transition more successfully to value-based care.